118 related articles for article (PubMed ID: 32783264)
1. Tolerance and efficacy of a new celastrol-containing balm as adjunct care in psoriasis.
Thouvenin MD; Dalmon S; Theunis J; Lauze C; Coubetergues H; Mengeaud V; Calvet B
J Eur Acad Dermatol Venereol; 2020 Aug; 34 Suppl 6():10-16. PubMed ID: 32783264
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies in Chinese subjects investigating the tolerance and soothing efficacy of a cream and balm containing 4-t-butylcyclohexanol on the sensitivity of facial skin.
Ortiz Brugués A; Braeuer LC; Grieu JB; Zhang Y
Int J Cosmet Sci; 2023 Feb; 45(1):29-37. PubMed ID: 36214607
[TBL] [Abstract][Full Text] [Related]
3. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.
Lebwohl MG; Sugarman JL; Stein Gold L; Lin T; Israel R
J Drugs Dermatol; 2019 Oct; 18(10):1012-1018. PubMed ID: 31584780
[TBL] [Abstract][Full Text] [Related]
5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
6. Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings.
Cowdell F; Jadotte YT; Ersser SJ; Danby S; Lawton S; Roberts A; Dyson J
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011377. PubMed ID: 32006460
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
Gottlieb AB; Ford RO; Spellman MC
J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
[TBL] [Abstract][Full Text] [Related]
8. DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis.
Fowler JF; Hebert AA; Sugarman J
J Drugs Dermatol; 2016 Feb; 15(2):154-62. PubMed ID: 26885782
[TBL] [Abstract][Full Text] [Related]
9. Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasis.
Jorizzo JL; Magee K; Stewart DM; Lebwohl MG; Rajagopalan R; Brown JJ
Cutis; 1997 Jul; 60(1):55-60. PubMed ID: 9252738
[TBL] [Abstract][Full Text] [Related]
10. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
[TBL] [Abstract][Full Text] [Related]
11. Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities.
Bhatia ND; Vlahovic TC; Green LG; Martin G; Lin T
J Drugs Dermatol; 2019 Oct; 18(10):1029-1036. PubMed ID: 31584782
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
13. Improvement in Extensive Moderate Plaque Psoriasis With a Novel Emollient Spray Formulation of Betamethasone Dipropionate 0.05.
Stein Gold L; Jackson JM; Knuckles ML; Weiss JS
J Drugs Dermatol; 2016 Mar; 15(3):334-42. PubMed ID: 26954319
[TBL] [Abstract][Full Text] [Related]
14. Desoximetasone 0.25% Spray for the Relief of Scaling in Adults With Plaque Psoriasis.
Keegan BR
J Drugs Dermatol; 2015 Aug; 14(8):835-40. PubMed ID: 26267727
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
Andreassi L; Giannetti A; Milani M;
Br J Dermatol; 2003 Jan; 148(1):134-8. PubMed ID: 12534607
[TBL] [Abstract][Full Text] [Related]
16. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis.
Bhatia N; Stein Gold L; Kircik LH; Schreiber R
J Drugs Dermatol; 2019 Aug; 18(8):790-796. PubMed ID: 31424709
[TBL] [Abstract][Full Text] [Related]
17. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
18. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity.
Meng S; Sun L; Wang L; Lin Z; Liu Z; Xi L; Wang Z; Zheng Y
Colloids Surf B Biointerfaces; 2019 Oct; 182():110352. PubMed ID: 31306831
[TBL] [Abstract][Full Text] [Related]
19. Enhanced response of childhood psoriasis to narrow-band UV-B phototherapy with preirradiation use of mineral oil.
Jain VK; Bansal A; Aggarwal K; Jain K
Pediatr Dermatol; 2008; 25(5):559-64. PubMed ID: 18950402
[TBL] [Abstract][Full Text] [Related]
20. Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study.
Amatya B; Wennersten G; Nordlind K
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):822-6. PubMed ID: 18422545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
